Catalyst
Slingshot members are tracking this event:
Trevena (TRVN) Presents Detailed Results from Phase 3 APOLLO-1 and APOLLO-2 Evaluating Olinvo (Oliceridine Injection) For the Management of Moderate-to-Severe Acute Pain in a Hospital Setting
- Source Link:
- http://epo.epostersonline.net/ASRASpring17/node/662
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TRVN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 06, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Apollo-1, Apollo-2, Olinvo, Oliceridine Injection, Moderate-to-severe Pain, Hospital Setting, Onestep-2 Pivotal Phase 3 Clinical Trial
